Clinical TrialsSearch results
Number of results: 902
Not yet recruiting
- A randomized competitive trial of BCG instillation therapy with UFT for prevention of superficial bladder cancer recurrence.
- Bladder cancer
- Study Group of Urothelial Cancer Kitasato institute hospital Kitasato University Kyorin University Keio University Showa University Teikyo University Tokyo Medical University Jikei University Toho University
- 2009-05-01
Other
- Phase 1/2 study of NS-401 in patients with blastic plasmacytoid dendritic cell neoplasm
- blastic plasmacytoid dendritic cell neoplasm
- Higashioka Masaya
- 2022-04-16
Other
- Randomized controlled trial to compare CMV antigenemia assay and real-time PCR after unrelated bone marrow transplantation.
- Bone marrow transplant recipients.
- Ministry of Health, Labor and Welfare of Japan
- 2006-03-10
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- A Phase II study of docetaxel (T) and cyclophosphamide(C) as adjuvant chemotherapy for patients with high risk, node negative, early stage breast cancer
- Breast cancer
- Japan East Cancer Center Breast Cancer Consortium
- 2006-10-01
Other
- Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
- Breast Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-03-06
Other
- Randomized controlled trial on effectiveness of ultrasonography in breast cancer screening(Japan Strategic Anti-Cancer Randomized Trial)
- Breast Cancer
- Division of Surgical Oncology, Graduate School of Medicine, TOHOKU UNIVERSITY
- 2007-07-01
Other
- Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2
- Breast Cancer
- Office for cordination of Herceptin trial
- 2007-03-23
Other
- Randomized phase II study with six cycles of Docetaxel/cyclophosphamide (TC) and 5-fluorouracil, epirubicin, and cyclophosphamide (FEC100) followed by docetaxel for treating hormone receptor-negative breast cancers
- Breast cancer
- Yokohama City University medical center Breast and thyroid surgery
- 2009-07-17
Other
- Randomized Study Comparing Electronic Patient Reported Outcomes(ePROs) Monitoring with Routine Follow Up During Trastuzumab Deruxtecan Treatment
- breast cancer
- Sangai Takafumi
- 2021-03-01